Download PDF
Horm Metab Res 2013; 45(10): 741-747
DOI: 10.1055/s-0033-1348221
Original Basic
© Georg Thieme Verlag KG Stuttgart · New York

CD40L Stimulates the Crosstalk Between Adipocytes and Inflammatory Cells

A. Chatzigeorgiou
1   Department of Internal Medicine III, University of Dresden, ­Dresden, Germany
2   Institute of Physiology, University of Dresden, Dresden, Germany
3   Paul-Langerhans Institute Dresden, German Center for Diabetes Research (DZD), Dresden, Germany
,
J. Phieler
1   Department of Internal Medicine III, University of Dresden, ­Dresden, Germany
2   Institute of Physiology, University of Dresden, Dresden, Germany
3   Paul-Langerhans Institute Dresden, German Center for Diabetes Research (DZD), Dresden, Germany
,
J. Gebler
1   Department of Internal Medicine III, University of Dresden, ­Dresden, Germany
2   Institute of Physiology, University of Dresden, Dresden, Germany
,
S. R. Bornstein
1   Department of Internal Medicine III, University of Dresden, ­Dresden, Germany
3   Paul-Langerhans Institute Dresden, German Center for Diabetes Research (DZD), Dresden, Germany
,
T. Chavakis
1   Department of Internal Medicine III, University of Dresden, ­Dresden, Germany
2   Institute of Physiology, University of Dresden, Dresden, Germany
3   Paul-Langerhans Institute Dresden, German Center for Diabetes Research (DZD), Dresden, Germany
4   Institute for Clinical Chemistry and Laboratory Medicine, University of Dresden, Dresden, Germany
› Author Affiliations
Further Information

Publication History

received 05 October 2012

accepted 14 May 2012

Publication Date:
05 August 2013 (online)

Also available at
    Permissions and Reprints

Abstract

Macrophages and lymphocytes are implicated in obesity-related adipose tissue inflammation via interactions with adipocytes. Co-stimulatory systems, especially the CD40-CD40L system, play an important role in T cell activation and inflammatory reactions. CD40L was recently shown to promote adipose tissue inflammation in vivo, yet, the mechanisms underlying its function in the intercellular communication between inflammatory cells and adipocytes remain not entirely clear. Here we found that adipocyte stimulation with CD40L increased the expression of CD40, as well as of chemokines, such as MCP-1, CCL4, or CCL5, whereas adipocyte CD40 expression was also stimulated by TNF but not palmitate. Moreover, conditioned media of CD40L-pretreated adipocytes provoked elevated migration of mononuclear cells and increased the expression of inflammatory genes in bone marrow derived mononuclear phagocytes (BMDM) shifting them to an M1-like pro-inflammatory phenotype. Nonetheless, the CD40/CD40L interaction did not contribute to the adhesion between adipocytes and T cells. Together, CD40L stimulates adipocyte chemokine expression, thereby attracting monocytes/macrophages into the adipose tissue. Moreover, CD40L stimulation of adipocytes likely promotes macrophage M1 polarization in the adipose tissue and thereby perpetuation of adipose tissue inflammation.

Key words

co-stimulation - T cells - macrophages - inflammation - obesity - CD40
 

  • References

  • 1 Anderson EK, Gutierrez DA, Hasty AH. Adipose tissue recruitment of leukocytes. Curr Opin Lipidol 2010; 21: 172-177
    CrossrefPubMedGoogle Scholar
  • 2 Surmi BK, Hasty AH. Macrophage infiltration into adipose tissue: initiation, propagation and remodeling. Future Lipidol 2008; 3: 545-556
    CrossrefPubMedGoogle Scholar
  • 3 Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003; 112: 1821-1830
    CrossrefPubMedGoogle Scholar
  • 4 Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011; 11: 85-97
    CrossrefPubMedGoogle Scholar
  • 5 Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007; 117: 175-184
    CrossrefPubMedGoogle Scholar
  • 6 Schenk S, Saberi M, Olefsky JM. Insulin sensitivity: modulation by nutrients and inflammation. J Clin Invest 2008; 118: 2992-3002
    CrossrefPubMedGoogle Scholar
  • 7 Westcott DJ, Delproposto JB, Geletka LM, Wang T, Singer K, Saltiel AR, Lumeng CN. MGL1 promotes adipose tissue inflammation and insulin resistance by regulating 7/4hi monocytes in obesity. J Exp Med 2009; 206: 3143-3156
    CrossrefPubMedGoogle Scholar
  • 8 Chatzigeorgiou A, Karalis KP, Bornstein SR, Chavakis T. Lymphocytes in obesity-related adipose tissue inflammation. Diabetologia 2012; 55: 2583-2592
    CrossrefPubMedGoogle Scholar
  • 9 Nishimura S, Manabe I, Nagasaki M, Eto K, Yamashita H, Ohsugi M, Otsu M, Hara K, Ueki K, Sugiura S, Yoshimura K, Kadowaki T, Nagai R. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 2009; 15: 914-920
    CrossrefPubMedGoogle Scholar
  • 10 Winer S, Chan Y, Paltser G, Truong D, Tsui H, Bahrami J, Dorfman R, Wang Y, Zielenski J, Mastonardi F, Maezawa Y, Drucker DJ, Engelman E, Winer D, Dosch H-M. Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med 2009; 15: 921-929
    CrossrefPubMedGoogle Scholar
  • 11 Chatzigeorgiou A, Lyberi M, Chatzilymperis G, Nezos A, Kamper E. CD40/CD40L signaling and its implication in health and disease. Biofactors 2009; 35: 474-483
    CrossrefPubMedGoogle Scholar
  • 12 van Kooten C, Banchereau J. CD40-CD40 ligand. J Leukoc Biol 2000; 67: 2-17
    PubMedGoogle Scholar
  • 13 Munroe ME. Functional roles for T cell CD40 in infection and autoimmune disease: the role of CD40 in lymphocyte homeostasis. Semin Immunol 2009; 21: 283-288
    CrossrefPubMedGoogle Scholar
  • 14 Engel D, Seijkens T, Poggi M, Sanati M, Thevissen L, Becker L, Wijnands E, Lievens D, Lutgens E. The immunobiology of CD154-CD40-TRAF interactions in atherosclerosis. Semin Immunol 2009; 21: 308-312
    CrossrefPubMedGoogle Scholar
  • 15 Lievens D, Eijgelaar WJ, Biessen EA, Daemen MJ, Lutgens E. The multi-functionality of CD40L and its receptor CD40 in atherosclerosis. Thromb Haemost 2009; 102: 206-214
    PubMedGoogle Scholar
  • 16 MacDonald KP, Nishioka Y, Lipsky PE, Thomas R. Functional CD40 ligand is expressed by T cells in rheumatoid arthritis. J Clin Invest 1997; 100: 2404-2414
    CrossrefPubMedGoogle Scholar
  • 17 Gerritse K, Laman JD, Noelle RJ, Aruffo A, Ledbetter JA, Boersma WJA, Classen E. CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc Natl Acad Sci USA 1996; 93: 2499-2504
    CrossrefPubMedGoogle Scholar
  • 18 Chatzigeorgiou A, Harokopos V, Mylona-Karagianni C, Tsouvalas E, Aidinis V, Kamper EF. The pattern of inflammatory/anti-inflammatory cytokines and chemokines in type 1 diabetic patients over time. Ann Med 2010; 42: 426-438
    CrossrefPubMedGoogle Scholar
  • 19 Laman JD, de Smet BJ, Schoneveld A, van Meurs M. CD40-CD40L interactions in atherosclerosis. Immunol Today 1997; 18: 272-277
    PubMedGoogle Scholar
  • 20 Missiou A, Wolf D, Platzer I, Ernst S, Walter C, Rudolf P, Zirlik K, Köstlin N, Willecke FK, Münkel C, Schönbeck U, Libby P, Bode C, Varo N, Zirlik A. CD40L induces inflammation and adipogenesis in adipose cells – a potential link between metabolic and cardiovascular disease. Thromb Haemost 2010; 103: 788-796
    Article in Thieme ConnectPubMedGoogle Scholar
  • 21 Poggi M, Jager J, Paulmyer-Lacroix O, Peiretti F, Gremeau XT, Verdier M, Grino M, Stepanian A, Misika S, Burcelin R, de Prost D, Tanti JF, Alessi MC. The inflammatory receptor CD40 is expressed on human adipocytes: contribution to crosstalk between lymphocytes and adipocytes. Diabetologia 2009; 52: 1152-1163
    CrossrefPubMedGoogle Scholar
  • 22 Cipollone F, Chiarelli F, Davi G, Ferri C, Desideri G, Fazia M, Iezzi A, Santilli F, Pini B, Cuccurullo C, Tumini S, Del Ponte A, Santucci A, Cuccurullo F, Mezzetti A. Enhanced soluble CD40 ligand contributes to endothelial cell dysfunction in vitro and monocyte activation in patients with diabetes mellitus: effect of improved metabolic control. Diabetologia 2005; 48: 1216-1224
    CrossrefPubMedGoogle Scholar
  • 23 Guldiken S, Demir M, Arikan E, Turgut B, Azcan S, Gerenli M, Tugrul A. The levels of circulating markers of atherosclerosis and inflammation in subjects with different degrees of body mass index: Soluble CD40 ligand and high-sensitivity C-reactive protein. Thromb Res 2007; 119: 79-84
    CrossrefPubMedGoogle Scholar
  • 24 Angelico F, Alessandri C, Ferro D, Pignatelli P, Del Ben M, Fiorello S, Cangemi R, Loffredo L, Violi F. Enhanced soluble CD40L in patients with the metabolic syndrome: Relationship with in vivo thrombin generation. Diabetologia 2006; 49: 1169-1174
    CrossrefPubMedGoogle Scholar
  • 25 Poggi M, Engel D, Christ A, Beckers L, Wijnands E, Boon L, Driessen A, Cleutjens J, Weber C, Gerdes N, Lutgens E. CD40L deficiency ameliorates adipose tissue inflammation and metabolic manifestations of obesity in mice. Arterioscler Thromb Vasc Biol 2011; 31: 2251-2260
    CrossrefPubMedGoogle Scholar
  • 26 Wolf D, Jehle F, Ortiz Rodriguez A, Dufner B, Hoppe N, Collberg C, Lozhkin A, Bassler N, Rupprecht B, Wiedemann A, Hilgendorf I, Stachon P, Willecke F, Febbraio M, von zur Muhlen C, Binder CJ, Bode C, Zirlik A, Peter K. CD40L deficiency attenuates diet-induced adipose tissue inflammation by impairing immune cell accumulation and production of pathogenic IgG-antibodies. PLoS One 2012; 7: e33026
    CrossrefPubMedGoogle Scholar
  • 27 Bradley RL, Fisher FF, Maratos-Flier E. Dietary fatty acids differentially regulate production of TNF-alpha and IL-10 by murine 3T3-L1 adipocytes. Obesity (Silver Spring) 2008; 16: 938-944
    CrossrefPubMedGoogle Scholar
  • 28 Yang L, Qian Z, Ji H, Yang R, Wang Y, Xi L, Shang L, Zhao B, Zhang X. Inhibitory effect on protein kinase Ctheta by Crocetin attenuates palmitate-induced insulin insensitivity in 3T3-L1 adipocytes. Eur J Pharmacol 2010; 642: 47-55
    CrossrefPubMedGoogle Scholar
  • 29 Rotter V, Nagaev I, Smith U. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem 2003; 278: 45777-45784
    CrossrefPubMedGoogle Scholar
  • 30 Castrillo A, Joseph SB, Marathe C, Mangelsdorf DJ, Tontonoz P. Liver X receptor-dependent repression of matrix metalloproteinase-9 expression in macrophages. J Biol Chem 2003; 278: 10443-10449
    CrossrefPubMedGoogle Scholar
  • 31 Lu B, Lu Y, Moser AH, Shigenaga JK, Grunfeld C, Feingold KR. LPS and proinflammatory cytokines decrease lipin-1 in mouse adipose tissue and 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 2008; 295: E1502-E1509
    CrossrefPubMedGoogle Scholar
  • 32 Choi EY, Orlova VV, Fagerholm SC, Nurmi SM, Zhang L, Ballantyne CM, Gahmberg CG, Chavakis T. Regulation of LFA-1-dependent inflammatory cell recruitment by Cbl-b and 14-3-3 proteins. Blood 2008; 111: 3607-3614
    CrossrefPubMedGoogle Scholar
  • 33 Chavakis T, Athanasopoulos A, Rhee JS, Orlova V, Schmidt-Wöll T, Bierhaus A, May AE, Celik I, Nawroth PP, Preissner T. Angiostatin is a novel anti-inflammatory factor by inhibiting leukocyte recruitment. Blood 2005; 105: 1036-1043
    PubMedGoogle Scholar
  • 34 Chavakis T, Santoso S, Clemetson KJ, Sachs UJ, Isordia-Salas I, Pixley RA, Nawroth PP, Colman RW, Preissner KT. High molecular weight kininogen regulates platelet-leukocyte interactions by bridging Mac-1 and glycoprotein Ib. J Biol Chem 2003; 278: 45375-45381
    CrossrefPubMedGoogle Scholar
  • 35 Keiper T, Al-Fakhri N, Chavakis E, Athanasopoulos AN, Isermann B, Herzog S, Saffrich R, Hersmeyer K, Bohle RM, Haenadder J, Preissner KT, Santoso S, Chavakis T. The role of junctional adhesion molecule-C (JAM-C) in oxidized LDL-mediated leukocyte recruitment. FASEB J 2005; 19: 2078-2080
    PubMedGoogle Scholar
  • 36 Choi EY, Chavakis E, Czabanka MA, Langer HF, Fraemohs L, Economopoulou M, Kundu RK, Orlandi A, Zheng YY, Prieto DA, Ballantyne CM, Constant SL, Aird WC, Papayannopoulou T, Gahmberg CG, Udey MC, Vajkoczy P, Quertermous T, Dimmeler S, Weber C, Chavakis T. Del-1, an endogenous leukocyte-endothelial adhesion inhibitor, limits inflammatory cell recruitment. Science 2008; 322: 1101-1104
    CrossrefPubMedGoogle Scholar
  • 37 Wu W, Alexis NE, Bromberg PA, Jaspers I, Peden DB. Mechanisms of LPS-induced CD40 expression in human peripheral blood monocytic cells. Biochem Biophys Res Commun 2009; 379: 573-577
    CrossrefPubMedGoogle Scholar
  • 38 Chai H, Yan S, Wang H, Zhang R, Lin PH, Yao Q, Chen C. CD40 ligand increases expression of its receptor CD40 in human coronary artery endothelial cells. Surgery 2006; 140: 236-242
    CrossrefPubMedGoogle Scholar
  • 39 Tone M, Tone Y, Fairchild PJ, Wykes M, Waldmann H. Regulation of CD40 function by its isoforms generated through alternative splicing. Proc Natl Acad Sci USA 2001; 98: 1751-1756
    CrossrefPubMedGoogle Scholar
  • 40 Fleetwood AJ, Dinh H, Cook AD, Hertzog PJ, Hamilton JA. GM-CSF- and M-CSF-dependent macrophage phenotypes display differential dependence on type I interferon signaling. J Leukoc Biol 2009; 86: 411-421
    CrossrefPubMedGoogle Scholar
  • 41 Gantner F, Leist M, Lohse AW, Germann PG, Tiegs G. Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 1995; 21: 190-198
    CrossrefPubMedGoogle Scholar
  • 42 Boilard E, Surette ME. Anti-CD3 and concanavalin A-induced human T cell proliferation is associated with an increased rate of arachidonate-phospholipid remodeling. Lack of involvement of group IV and group VI phospholipase A2 in remodeling and increased susceptibility of proliferating T cells to CoA-independent transacyclase inhibitor-induced apoptosis. J Biol Chem 2001; 276: 17568-17575
    CrossrefPubMedGoogle Scholar
  • 43 De Taeye BM, Novitskaya T, McGuinness OP, Gleaves L, Medda M, Covington JW, Vaughan DE. Macrophage TNF-alpha contributes to insulin resistance and hepatic steatosis in diet-induced obesity. Am J Physiol Endocrinol Metab 2007; 293: E713-E725
    CrossrefPubMedGoogle Scholar
  • 44 Kaminski DA, Randall TD. Adaptive immunity and adipose tissue biology. Trends Immunol 2010; 31: 384-390
    CrossrefPubMedGoogle Scholar